Key Record Dates
ClinicalTrials.gov Identifier: | NCT05904470 |
---|---|
Brief Title: | A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV |
First Submitted : | June 6, 2023 |
First Submitted that Met QC Criteria : | June 6, 2023 |
First Posted : | June 15, 2023 |
Last Update Submitted that Met QC Criteria : | May 10, 2024 |
Last Update Posted : | May 14, 2024 |